Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 3 May 2002:
Vol. 296. no. 5569, pp. 920 - 922
DOI: 10.1126/science.1068452
Prev | Table of Contents | Next

Reports

Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor Environment

Yuan Zhu,1 Pritam Ghosh,1 Patrick Charnay,3 Dennis K. Burns,2 Luis F. Parada1*

Neurofibromatosis type 1 (NF1) is one of the most prevalent dominantly inherited genetic diseases of the nervous system. NF1 encodes a tumor suppressor whose functional loss results in the development of benign neurofibromas that can progress to malignancy. Neurofibromas are complex tumors composed of axonal processes, Schwann cells, fibroblasts, perineurial cells, and mast cells. Through use of a conditional (cre/lox) allele, we show that loss of NF1 in the Schwann cell lineage is sufficient to generate tumors. In addition, complete NF1-mediated tumorigenicity requires both a loss of NF1 in cells destined to become neoplastic as well as heterozygosity in non-neoplastic cells. The requirement for a permissive haploinsufficient environment to allow tumorigenesis may have therapeutic implications for NF1 and other familial cancers.

1 Center for Developmental Biology,
2 Department of Pathology, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390-9133, USA.
3 Ecole Normale Superieure, 46 rue d'Ulm 75230, Paris, Cedex 05, France.
*   To whom correspondence should be addressed. E-mail: luis.parada{at}utsouthwestern.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
PTEN dosage is essential for neurofibroma development and malignant transformation.
C. Gregorian, J. Nakashima, S. M. Dry, P. L. Nghiemphu, K. B. Smith, Y. Ao, J. Dang, G. Lawson, I. K. Mellinghoff, P. S. Mischel, et al. (2009)
PNAS 106, 19479-19484
   Abstract »    Full Text »    PDF »
Sustained Axon-Glial Signaling Induces Schwann Cell Hyperproliferation, Remak Bundle Myelination, and Tumorigenesis.
J. A. Gomez-Sanchez, M. Lopez de Armentia, R. Lujan, N. Kessaris, W. D. Richardson, and H. Cabedo (2009)
J. Neurosci. 29, 11304-11315
   Abstract »    Full Text »    PDF »
Multiple sclerosis and neurofibromatosis type 1: report of seven patients from Iran.
M Etemadifar, F Fatehi, M. Sahraian, A Borhanihaghighi, P. Ardestani, M Kaji-Esfahani, and A. Maghzi (2009)
Multiple Sclerosis 15, 1126-1130
   Abstract »    PDF »
Disease models and mechanisms in the classroom.
A. D. Gitler (2009)
Dis. Model. Mech. 2, 103-106
   Full Text »    PDF »
NF1 loss disrupts Schwann cell-axonal interactions: a novel role for semaphorin 4F.
S. Parrinello, L. A. Noon, M. C. Harrisingh, P. W. Digby, L. H. Rosenberg, C. A. Cremona, P. Echave, A. M. Flanagan, L. F. Parada, and A. C. Lloyd (2008)
Genes & Dev. 22, 3335-3348
   Abstract »    Full Text »    PDF »
Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells.
A. S. McDaniel, J. D. Allen, S.-J. Park, Z. M Jaffer, E. G. Michels, S. J. Burgin, S. Chen, W. K. Bessler, C. Hofmann, D. A. Ingram, et al. (2008)
Blood 112, 4646-4654
   Abstract »    Full Text »    PDF »
Using Neurofibromatosis-1 to Better Understand and Treat Pediatric Low-Grade Glioma.
D. H. Gutmann (2008)
J Child Neurol 23, 1186-1194
   Abstract »    PDF »
Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis.
B. Hegedus, T.-H. Yeh, D. Y. Lee, R. J. Emnett, J. Li, and D. H. Gutmann (2008)
Hum. Mol. Genet. 17, 2956-2966
   Abstract »    Full Text »    PDF »
Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway.
E. A. Lasater, W. K. Bessler, L. E. Mead, W. E. Horn, D. W. Clapp, S. J. Conway, D. A. Ingram, and F. Li (2008)
Hum. Mol. Genet. 17, 2336-2344
   Abstract »    Full Text »    PDF »
Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcomas.
S. L. Spunt, S. X. Skapek, and C. M. Coffin (2008)
Oncologist 13, 668-678
   Abstract »    Full Text »    PDF »
Mast cells are an essential hematopoietic component for polyp development.
E. Gounaris, S. E. Erdman, C. Restaino, M. F. Gurish, D. S. Friend, F. Gounari, D. M. Lee, G. Zhang, J. N. Glickman, K. Shin, et al. (2007)
PNAS 104, 19977-19982
   Abstract »    Full Text »    PDF »
Targeting oncogenic Ras.
E. Diaz-Flores and K. Shannon (2007)
Genes & Dev. 21, 1989-1992
   Full Text »    PDF »
Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.
G. C. Daginakatte and D. H. Gutmann (2007)
Hum. Mol. Genet. 16, 1098-1112
   Abstract »    Full Text »    PDF »
New mouse models of cancer: Single-cell knockouts.
G. Lozano and R. R. Behringer (2007)
PNAS 104, 4245-4246
   Full Text »    PDF »
Systemic Stromal Effects of Estrogen Promote the Growth of Estrogen Receptor-Negative Cancers.
P. B. Gupta, D. Proia, O. Cingoz, J. Weremowicz, S. P. Naber, R. A. Weinberg, and C. Kuperwasser (2007)
Cancer Res. 67, 2062-2071
   Abstract »    Full Text »    PDF »
K-ras Is Critical for Modulating Multiple c-kit-Mediated Cellular Functions in Wild-Type and Nf1+/- Mast Cells.
W. F. Khalaf, F.-C. Yang, S. Chen, H. White, W. Bessler, D. A. Ingram, and D. W. Clapp (2007)
J. Immunol. 178, 2527-2534
   Abstract »    Full Text »    PDF »
{beta} common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice.
A. Kim, K. Morgan, D. E. Hasz, S. M. Wiesner, J. O. Lauchle, J. L. Geurts, M. D. Diers, D. T. Le, S. C. Kogan, L. F. Parada, et al. (2007)
Blood 109, 1687-1691
   Abstract »    Full Text »    PDF »
Microarray-Based Identification of Tenascin C and Tenascin XB, Genes Possibly Involved in Tumorigenesis Associated with Neurofibromatosis Type 1.
P. Levy, H. Ripoche, I. Laurendeau, V. Lazar, N. Ortonne, B. Parfait, K. Leroy, J. Wechsler, I. Salmon, P. Wolkenstein, et al. (2007)
Clin. Cancer Res. 13, 398-407
   Abstract »    Full Text »    PDF »
Phosphatidylinositol 3-Kinase and Akt Nonautonomously Promote Perineurial Glial Growth in Drosophila Peripheral Nerves.
W. Lavery, V. Hall, J. C. Yager, A. Rottgers, M. C. Wells, and M. Stern (2007)
J. Neurosci. 27, 279-288
   Abstract »    Full Text »    PDF »
Reduced growth of Drosophila neurofibromatosis 1 mutants reflects a non-cell-autonomous requirement for GTPase-Activating Protein activity in larval neurons.
J. A. Walker, A. V. Tchoudakova, P. T. McKenney, S. Brill, D. Wu, G. S. Cowley, I. K. Hariharan, and A. Bernards (2006)
Genes & Dev. 20, 3311-3323
   Abstract »    Full Text »    PDF »
Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells.
X. Wu, S. A. Estwick, S. Chen, M. Yu, W. Ming, T. D. Nebesio, Y. Li, J. Yuan, R. Kapur, D. Ingram, et al. (2006)
Hum. Mol. Genet. 15, 2837-2845
   Abstract »    Full Text »    PDF »
Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-{beta} signaling.
F.-C. Yang, S. Chen, T. Clegg, X. Li, T. Morgan, S. A. Estwick, J. Yuan, W. Khalaf, S. Burgin, J. Travers, et al. (2006)
Hum. Mol. Genet. 15, 2421-2437
   Abstract »    Full Text »    PDF »
Pathophysiology of neurofibromatosis type 1..
A. Theos and B. R. Korf (2006)
Ann Intern Med 144, 842-849
   Full Text »    PDF »
Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells.
F. Li, A. M. Munchhof, H. A. White, L. E. Mead, T. R. Krier, A. Fenoglio, S. Chen, X. Wu, S. Cai, F.-C. Yang, et al. (2006)
Hum. Mol. Genet. 15, 1921-1930
   Abstract »    Full Text »    PDF »
Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells.
A. M. Munchhof, F. Li, H. A. White, L. E. Mead, T. R. Krier, A. Fenoglio, X. Li, J. Yuan, F.-C. Yang, and D. A. Ingram (2006)
Hum. Mol. Genet. 15, 1858-1869
   Abstract »    Full Text »    PDF »
Normal Stem Cells and Cancer Stem Cells: The Niche Matters..
L. Li and W. B. Neaves (2006)
Cancer Res. 66, 4553-4557
   Abstract »    Full Text »    PDF »
Perinatal Epidermal Growth Factor Receptor Blockade Prevents Peripheral Nerve Disruption in a Mouse Model Reminiscent of Benign World Health Organization Grade I Neurofibroma.
J. Wu, J. T. Crimmins, K. R. Monk, J. P. Williams, M. E. Fitzgerald, S. Tedesco, and N. Ratner (2006)
Am. J. Pathol. 168, 1686-1696
   Abstract »    Full Text »    PDF »
An Imprinted Locus Epistatically Influences Nstr1 and Nstr2 to Control Resistance to Nerve Sheath Tumors in a Neurofibromatosis Type 1 Mouse Model.
K. M. Reilly, K. W. Broman, R. T. Bronson, S. Tsang, D. A. Loisel, E. S. Christy, Z. Sun, J. Diehl, D. J. Munroe, and R. G. Tuskan (2006)
Cancer Res. 66, 62-68
   Abstract »    Full Text »    PDF »
Tight Junction Proteins and Perineurial Cells in Neurofibromas.
K. P. Pummi, H. J. Aho, M. K. Laato, J. T.K. Peltonen, and S. A. Peltonen (2006)
J. Histochem. Cytochem. 54, 53-61
   Abstract »    Full Text »    PDF »
Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation.
Y. Zhu, T. Harada, L. Liu, M. E. Lush, F. Guignard, C. Harada, D. K. Burns, M. L. Bajenaru, D. H. Gutmann, and L. F. Parada (2005)
Development 132, 5577-5588
   Abstract »    Full Text »    PDF »
Tumor suppressor genetics.
S. R. Payne and C. J. Kemp (2005)
Carcinogenesis 26, 2031-2045
   Abstract »    Full Text »    PDF »
The Neurofibromatosis Type 1 Gene Product Neurofibromin Enhances Cell Motility by Regulating Actin Filament Dynamics via the Rho-ROCK-LIMK2-Cofilin Pathway.
T. Ozawa, N. Araki, S. Yunoue, H. Tokuo, L. Feng, S. Patrakitkomjorn, T. Hara, Y. Ichikawa, K. Matsumoto, K. Fujii, et al. (2005)
J. Biol. Chem. 280, 39524-39533
   Abstract »    Full Text »    PDF »
Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin.
A. I. McClatchey and M. Giovannini (2005)
Genes & Dev. 19, 2265-2277
   Abstract »    Full Text »    PDF »
Bupivacaine Induces Apoptosis via ROS in the Schwann Cell Line.
C.J. Park, S.A. Park, T.G. Yoon, S.J. Lee, K.W. Yum, and H.J. Kim (2005)
Journal of Dental Research 84, 852-857
   Abstract »    Full Text »    PDF »
Hypokalemic Rhabdomyolysis due to WDHA Syndrome Caused by VIP-producing Composite Pheochromocytoma: A Case in Neurofibromatosis Type 1.
M. Onozawa, T. Fukuhara, M. Minoguchi, M. Takahata, Y. Yamamoto, T. Miyake, K. Kanagawa, M. Kanda, and I. Maekawa (2005)
Jpn. J. Clin. Oncol. 35, 559-563
   Abstract »    Full Text »    PDF »
Hereditary Hormone Excess: Genes, Molecular Pathways, and Syndromes.
S. J. Marx and W. F. Simonds (2005)
Endocr. Rev. 26, 615-661
   Abstract »    Full Text »    PDF »
The NF1 tumor suppressor critically regulates TSC2 and mTOR.
C. M. Johannessen, E. E. Reczek, M. F. James, H. Brems, E. Legius, and K. Cichowski (2005)
PNAS 102, 8573-8578
   Abstract »    Full Text »    PDF »
A Mouse Model for the Carney Complex Tumor Syndrome Develops Neoplasia in Cyclic AMP-Responsive Tissues.
L. S. Kirschner, D. F. Kusewitt, L. Matyakhina, W. H. Towns II, J. A. Carney, H. Westphal, and C. A. Stratakis (2005)
Cancer Res. 65, 4506-4514
   Abstract »    Full Text »    PDF »
Suppression of Melanotroph Carcinogenesis Leads to Accelerated Progression of Pituitary Anterior Lobe Tumors and Medullary Thyroid Carcinomas in Rb+/- Mice.
Z. Zhou, A. Flesken-Nikitin, C. G. Levine, E. N. Shmidt, J. P. Eng, E. Yu. Nikitina, D. M. Spencer, and A. Yu. Nikitin (2005)
Cancer Res. 65, 787-796
   Abstract »    Full Text »    PDF »
Modeling Neurofibromatosis Type 1 Tumors in the Mouse for Therapeutic Intervention.
L.F. PARADA, C.-H. KWON, and Y. ZHU (2005)
Cold Spring Harb Symp Quant Biol 70, 173-176
   Abstract »    PDF »
Neural crest stem cells undergo multilineage differentiation in developing peripheral nerves to generate endoneurial fibroblasts in addition to Schwann cells.
N. M. Joseph, Y.-s. Mukouyama, J. T. Mosher, M. Jaegle, S. A. Crone, E.-L. Dormand, K.-F. Lee, D. Meijer, D. J. Anderson, and S. J. Morrison (2004)
Development 131, 5599-5612
   Abstract »    Full Text »    PDF »
Mechanisms and Roles of Axon-Schwann Cell Interactions.
G. Corfas, M. O. Velardez, C.-P. Ko, N. Ratner, and E. Peles (2004)
J. Neurosci. 24, 9250-9260
   Full Text »    PDF »
Molecular Profiles of Neurofibromatosis Type 1-Associated Plexiform Neurofibromas: Identification of a Gene Expression Signature of Poor Prognosis.
P. Levy, I. Bieche, K. Leroy, B. Parfait, J. Wechsler, I. Laurendeau, P. Wolkenstein, M. Vidaud, and D. Vidaud (2004)
Clin. Cancer Res. 10, 3763-3771
   Abstract »    Full Text »    PDF »
Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder.
D. T. Le, N. Kong, Y. Zhu, J. O. Lauchle, A. Aiyigari, B. S. Braun, E. Wang, S. C. Kogan, M. M. Le Beau, L. Parada, et al. (2004)
Blood 103, 4243-4250
   Abstract »    Full Text »    PDF »
Comparative Pathology of Nerve Sheath Tumors in Mouse Models and Humans.
A. O. Stemmer-Rachamimov, D. N. Louis, G. P. Nielsen, C. R. Antonescu, A. D. Borowsky, R. T. Bronson, D. K. Burns, P. Cervera, M. E. McLaughlin, G. Reifenberger, et al. (2004)
Cancer Res. 64, 3718-3724
   Abstract »    Full Text »    PDF »
Myristoylation of the Fus1 Protein Is Required for Tumor Suppression in Human Lung Cancer Cells.
F. Uno, J. Sasaki, M. Nishizaki, G. Carboni, K. Xu, E. N. Atkinson, M. Kondo, J. D. Minna, J. A. Roth, and L. Ji (2004)
Cancer Res. 64, 2969-2976
   Abstract »    Full Text »    PDF »
Loss of the Nf1 Tumor Suppressor Gene Decreases Fas Antigen Expression in Myeloid Cells.
K. Hiatt, D. A. Ingram, H. Huddleston, D. F. Spandau, R. Kapur, and D. W. Clapp (2004)
Am. J. Pathol. 164, 1471-1479
   Abstract »    Full Text »    PDF »
Watch thy neighbor: cancer is a communal affair.
V. M. Weaver and P. Gilbert (2004)
J. Cell Sci. 117, 1287-1290
   Abstract »    Full Text »    PDF »
Mouse Models of Human Familial Cancer Syndromes.
J. M. Ward and D. E. Devor-Henneman (2004)
Toxicol Pathol 32, 90-98
   Abstract »    PDF »
Optic Nerve Glioma in Mice Requires Astrocyte Nf1 Gene Inactivation and Nf1 Brain Heterozygosity.
M. L. Bajenaru, M. R. Hernandez, A. Perry, Y. Zhu, L. F. Parada, J. R. Garbow, and D. H. Gutmann (2003)
Cancer Res. 63, 8573-8577
   Abstract »    Full Text »    PDF »
Mouse Models of Human Cancer Consortium Symposium on Nervous System Tumors.
D. H. Gutmann, S. J. Baker, M. Giovannini, J. Garbow, and W. Weiss (2003)
Cancer Res. 63, 3001-3004
   Abstract »    Full Text »    PDF »
Neurofibromatosis 1: A Novel NF1 Mutation in an 11-Year-Old Girl With a Giant Cell Granuloma.
U. Krammer, K. Wimmer, P. Wiesbauer, M. Rasse, S. Lang, A. Mullner-Eidenbock, and H. Frisch (2003)
J Child Neurol 18, 371-373
   Abstract »    PDF »
Brain Lipid Binding Protein in Axon-Schwann Cell Interactions and Peripheral Nerve Tumorigenesis.
S. J. Miller, H. Li, T. A. Rizvi, Y. Huang, G. Johansson, J. Bowersock, A. Sidani, J. Vitullo, K. Vogel, L. M. Parysek, et al. (2003)
Mol. Cell. Biol. 23, 2213-2224
   Abstract »    Full Text »    PDF »
Leukemic potential of doubly mutant Nf1 and Wv hematopoietic cells.
D. A. Ingram, M. J. Wenning, K. Shannon, and D. W. Clapp (2003)
Blood 101, 1984-1986
   Abstract »    Full Text »    PDF »
Haploinsufficiency of p18INK4c Sensitizes Mice to Carcinogen-Induced Tumorigenesis.
F. Bai, X.-H. Pei, V. L. Godfrey, and Y. Xiong (2003)
Mol. Cell. Biol. 23, 1269-1277
   Abstract »    Full Text »    PDF »
Progesterone Receptor Expression in Neurofibromas.
M. E. McLaughlin and T. Jacks (2003)
Cancer Res. 63, 752-755
   Abstract »    Full Text »    PDF »
Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor.
K. Cichowski, S. Santiago, M. Jardim, B. W. Johnson, and T. Jacks (2003)
Genes & Dev. 17, 449-454
   Abstract »    Full Text »    PDF »
A Novel Cytokine Pathway Suppresses Glial Cell Melanogenesis after Injury to Adult Nerve.
T. A. Rizvi, Y. Huang, A. Sidani, R. Atit, D. A. Largaespada, R. E. Boissy, and N. Ratner (2002)
J. Neurosci. 22, 9831-9840
   Abstract »    Full Text »    PDF »
Neurofibromas: Schwann Cells and Stroma.
(2002)
Journal Watch Dermatology 2002, 5
   Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)